Atlas Trials

Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism

Clinical trial NCT02898051 · UNKNOWN

Trial details

NCT number
NCT02898051
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Study type
OBSERVATIONAL
NeoplasmsVenous Thromboembolism
Start date
2011-08-01
Primary completion
2017-10-01
Enrollment
370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.